NCT02586194View on ClinicalTrials.gov

Pharmacokinetics Study in Patients With Impaired Hepatic Function

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

December 28, 2015

Primary Completion Date

September 27, 2016

Study Completion Date

September 27, 2016

Conditions
Patients With Impaired Hepatic Function
Interventions
DRUG

ASP015K

Oral

Trial Locations (6)

Unknown

Site JP00001, Fukuoka

Site JP00003, Kanagawa

Site JP00002, Tokyo

Site JP00004, Tokyo

Site JP00005, Tokyo

Site JP00006, Tokyo

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY